✦ LIBER ✦

A randomized phase II trial of aminoglutethimide and hydrocortisone versus combined aminoglutethimide, hydrocortisone and fluoxymesterone in advanced breast cancer

✍ Scribed by Gennatas, Constantine S.; Kalovidouris, Angelos; Paraskevas, George A.; Kouvaris, John; Trichopoulos, Demetrios; Papavasiliou, Constantine

Book ID: 123105447
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 282 KB
Volume: 9
Category: Article
ISSN: 0167-8140
DOI: 10.1016/S0167-8140(87)80233-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of low dose aminoglutethi

Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer

✍ Harris, Adrian L.; Cantwell, Brian M.J.; Carmichael, James; Dawes, Peter; Robins 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 712 KB

A randomized trial of aminoglutethimide

A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer

✍ A. Lipton; H. A. Harvey; R. J. Santen; A. Boucher; D. White; A. Bernath; R. Dixo 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 2 views

Combined endocrine treatment of elderly

Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer; A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age

✍ Carsten Rose; Claus Kamby; Henning T. Mouridsen; Michael Andersson; Lars Basthol 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 58 KB

TREATMENT OF DISSEMINATED BREAST CANCER

TREATMENT OF DISSEMINATED BREAST CANCER WITH TAMOXIFEN, AMINOGLUTETHIMIDE, HYDROCORTISONE, AND DANAZOL, USED IN COMBINATION OR SEQUENTIALLY

✍ Powles, T.J; Ford, H.T; Nash, A.G; Ashley, S; Gazet, J.C; Neville, A.M; Coombes, 📂 Article 📅 1984 🏛 The Lancet 🌐 English ⚖ 709 KB

Buserelin (B) in association with aminog

Buserelin (B) in association with aminoglutethimide (AG) and hydrocortisone (HC) In advanced breast cancer (ABC). preliminary results

✍ V. Ferrari; A. Zaniboni; P. Marpicati; E. Simoncini; G. Arcangeli; F. Gorni; A. 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Second line endocrine treatment of postm

Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-ARM randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861)

✍ Bruning, P.F.; Bonfrèr, J.M.G.; Wildiers, J.; Jassem, J.; Beex, L.V.A.M.; Schorn 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 514 KB